BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17900987)

  • 1. 'Sensing' autoimmunity in type 1 diabetes.
    Tsui H; Razavi R; Chan Y; Yantha J; Dosch HM
    Trends Mol Med; 2007 Oct; 13(10):405-13. PubMed ID: 17900987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.
    Razavi R; Chan Y; Afifiyan FN; Liu XJ; Wan X; Yantha J; Tsui H; Tang L; Tsai S; Santamaria P; Driver JP; Serreze D; Salter MW; Dosch HM
    Cell; 2006 Dec; 127(6):1123-35. PubMed ID: 17174891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet glia, neurons, and beta cells.
    Tsui H; Winer S; Chan Y; Truong D; Tang L; Yantha J; Paltser G; Dosch HM
    Ann N Y Acad Sci; 2008 Dec; 1150():32-42. PubMed ID: 19120264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
    Tisch R; Wang B
    Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of 'fulminant type 1 diabetes'.
    Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory neurons link the nervous system and autoimmune diabetes.
    Bour-Jordan H; Bluestone JA
    Cell; 2006 Dec; 127(6):1097-9. PubMed ID: 17174888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Sensing' the link between type 1 and type 2 diabetes.
    Tsui H; Paltser G; Chan Y; Dorfman R; Dosch HM
    Diabetes Metab Res Rev; 2011 Nov; 27(8):913-8. PubMed ID: 22069284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.
    Planas R; Pujol-Borrell R; Vives-Pi M
    Immunol Lett; 2010 Oct; 133(2):55-61. PubMed ID: 20708640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
    Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
    Khadra A; Santamaria P; Edelstein-Keshet L
    J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Chen YG
    Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons on autoimmune diabetes from animal models.
    Yang Y; Santamaria P
    Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
    Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
    Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
    Yang Z; Chen M; Carter JD; Nunemaker CS; Garmey JC; Kimble SD; Nadler JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1017-22. PubMed ID: 16643856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.